ARCHIVES

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Obituary: Martin Abeloff, 65, Cancer Center Director At Johns Hopkins.

September 21, 2007

European Agency Recommends Transfusions Over ESAs For Cancer Patients With Longer Life Expectancy.

June 27, 2008

Calif. Stem Cell Group To Collaborate With Canadians.

June 20, 2008

Texts Of Workshop Report Summarized

November 8, 1996

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

May 16, 2008

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011